Healthcare of Ontario Pension Plan (HOOPP) Trust Fund’s BioCryst Pharmaceuticals BCRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$18.4M Buy
1,844,912
+617,872
+50% +$5.59M 0.03% 463
2026
Q1
$11.7M Buy
+1,227,040
New +$9.53M 0.02% 501
2025
Q3
– Sell
-512,200
Closed -$4.59M – 1189
2025
Q2
$4.59M Buy
+512,200
New +$4.77M 0.01% 524
2024
Q1
– Sell
-384,000
Closed -$2.3M – 942
2023
Q4
$2.3M Hold
384,000
– – 0.01% 607
2023
Q3
$2.72M Buy
+384,000
New +$2.76M 0.01% 490

Other funds holding BCRX

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund's BCRX Position: Q2 2026 in Review

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund increased its BioCryst Pharmaceuticals (BCRX) stake by 50% in Q2 2026, buying an estimated $5.59M and bringing the position to 1,844,912 shares worth $18.4M. The position accounts for 0.03% of the portfolio, ranked #463.

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund first reported a position in BCRX in Q3 2023 and has held it in 5 quarters since. 319 funds tracked by Wall St. Rank hold BCRX as of Q2 2026.

  • Healthcare of Ontario Pension Plan (HOOPP) Trust Fund held 1,844,912 shares of BioCryst Pharmaceuticals worth $18.4M as of Q2 2026.
  • Healthcare of Ontario Pension Plan (HOOPP) Trust Fund bought 617,872 BioCryst Pharmaceuticals shares in Q2 2026, an estimated $5.59M.
  • BioCryst Pharmaceuticals made up 0.03% of Healthcare of Ontario Pension Plan (HOOPP) Trust Fund's portfolio in Q2 2026, its #463 holding.
  • Healthcare of Ontario Pension Plan (HOOPP) Trust Fund first reported a position in BioCryst Pharmaceuticals in Q3 2023 and has held it in 5 quarters since.
  • 319 funds tracked by Wall St. Rank held BioCryst Pharmaceuticals as of Q2 2026.

Based on Healthcare of Ontario Pension Plan (HOOPP) Trust Fund's 13F filing for Q2 2026, filed 13 Aug 2026.